The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients
Status:
Completed
Trial end date:
2007-09-14
Target enrollment:
Participant gender:
Summary
The sustained reduction in elevated blood pressure and lower incidence of adverse events of
Lacidipine may provide additional benefits for hypertension patients than other CCBs (calcium
channel blockers). This study is to compare the efficacy and safety of Lacidipine with
Amlodipine, the most widely used CCB in Taiwan, in hypertensive patients.